021-51111890
购物车（）
sales@molnova.cn
Ruplizumab
CAS No. 220651-94-5
Ruplizumab ( —— )
产品货号. M36733 CAS No. 220651-94-5
Ruplizumab (BG 9588) 是一种人源化单克隆抗 CD40L (TNF Receptor) IgG1κ 抗体。Ruplizumab 具有用于系统性红斑狼疮疾病研究的潜力。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥4731 | 有现货 |
|
| 10MG | ￥6536 | 有现货 |
|
| 25MG | ￥9179 | 有现货 |
|
| 50MG | ￥12741 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ruplizumab
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Ruplizumab (BG 9588) 是一种人源化单克隆抗 CD40L (TNF Receptor) IgG1κ 抗体。Ruplizumab 具有用于系统性红斑狼疮疾病研究的潜力。
-
产品描述Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number220651-94-5
-
分子量
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Chris Chamberlain, et al. Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. Ann Rheum Dis. 2017 Nov;76(11):1837-1844.?
产品手册
关联产品
-
(Iso)-WAY-260022
(Iso)-WAY-260022 ((Iso)-NRI-022) is a stereoisomer of WAY-260022, a norepinephrine reuptake inhibitor and selective inhibitor of 5-hydroxytryptamine and dopamine transport proteins.
-
InsB 9-23
InsB (9-23) is an insulin B-chain peptide that binds to a class II histocompatibility complex (MHC) allele called I-Ag7.
-
Pseudo Vardenafil
Pseudo Vardenafil
